Arcturus Therapeutics Holdings Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported revenue was USD 80.29 million compared to USD 5.24 million a year ago. Net income was USD 50.75 million compared to net loss of USD 51.17 million a year ago.

Basic earnings per share from continuing operations was USD 1.91 compared to basic loss per share from continuing operations of USD 1.94 a year ago. Diluted earnings per share from continuing operations was USD 1.87 compared to diluted loss per share from continuing operations of USD 1.94 a year ago.